Yoshihiko Miyata

Kyoto, 6068501, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Mapping the Brain Interaction Network of the Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Targeted by Leucettinib-21 Using Affinity Chromatography.

Mapping the Brain Interaction Network of the Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Targeted by Leucettinib-21 Using Affinity Chromatography.

Journal: ACS pharmacology & translational science

Published: February 04, 2026

MAPK/MAK/MRK overlapping kinase (MOK) controls microglial inflammatory/type-I IFN responses via Brd4 and is involved in ALS.

MAPK/MAK/MRK overlapping kinase (MOK) controls microglial inflammatory/type-I IFN responses via Brd4 and is involved in ALS.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 03, 2023

Identification of FAM53C as a cytosolic-anchoring inhibitory binding protein of the kinase DYRK1A.

Identification of FAM53C as a cytosolic-anchoring inhibitory binding protein of the kinase DYRK1A.

Journal: Life science alliance

Published: May 03, 2023

A cyclic lipopeptide surfactin is a species-selective Hsp90 inhibitor that suppresses cyanobacterial growth.

A cyclic lipopeptide surfactin is a species-selective Hsp90 inhibitor that suppresses cyanobacterial growth.

Journal: Journal of biochemistry

Published: November 23, 2020

Protein quality control of DYRK family protein kinases by the Hsp90-Cdc37 molecular chaperone.

Protein quality control of DYRK family protein kinases by the Hsp90-Cdc37 molecular chaperone.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: December 25, 2019

Structural characterization of the N-terminal kinase-interacting domain of an Hsp90-cochaperone Cdc37 by CD and solution NMR spectroscopy.

Structural characterization of the N-terminal kinase-interacting domain of an Hsp90-cochaperone Cdc37 by CD and solution NMR spectroscopy.

Journal: Biochimica et biophysica acta. Proteins and proteomics

Published: March 08, 2019

Stimulation of the ATPase activity of Hsp90 by zerumbone modification of its cysteine residues destabilizes its clients and causes cytotoxicity.

Stimulation of the ATPase activity of Hsp90 by zerumbone modification of its cysteine residues destabilizes its clients and causes cytotoxicity.

Journal: The Biochemical journal

Published: March 19, 2018

Phosphorylation, Signaling, and Cancer: Targets and Targeting.

Phosphorylation, Signaling, and Cancer: Targets and Targeting.

Journal: BioMed research international

Published: October 08, 2015

The molecular chaperone TRiC/CCT binds to the Trp-Asp 40 (WD40) repeat protein WDR68 and promotes its folding, protein kinase DYRK1A binding, and nuclear accumulation.

The molecular chaperone TRiC/CCT binds to the Trp-Asp 40 (WD40) repeat protein WDR68 and promotes its folding, protein kinase DYRK1A binding, and nuclear accumulation.

Journal: The Journal of biological chemistry

Published: October 25, 2014

Protein kinase CK2 inhibition is associated with the destabilization of HIF-1α in human cancer cells.

Protein kinase CK2 inhibition is associated with the destabilization of HIF-1α in human cancer cells.

Journal: Cancer letters

Published: September 01, 2014

Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells.

Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells.

Journal: PloS one

Published: August 09, 2012

The therapeutic target Hsp90 and cancer hallmarks.

The therapeutic target Hsp90 and cancer hallmarks.

Journal: Current pharmaceutical design

Published: July 25, 2012

Showing 1-12 of 22

Last Updated: 09/26/2026